Briefing

Featured article

Illumina may be on its way to divest Grail, but legal trouble looms

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates

Trends & Insight

05/23/2024 01:45:24
  • Home | High-tech intimacy
  • Editor's letter
  • Contents
  • Formacoat Company Insight
  • Formacoat
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Techimount
  • Micro Systems
  • In Depth
  • High-tech intimacy: the devices tackling female sexual dysfunction 
  • The rise of home-based medical devices in ageing populations
  • AI’s data fakery is ‘scary’, but the problem is already huge
  • Roche on personalised medicine’s potential
  • NICE 2023: AI in focus
  • FT Summit: AI and regulatory changes at the forefront of industry’s mind
  • Mimotopes Company Insight
  • Arrow Electronics
  • Yearbook
  • Yearbook contents
  • 10 MedTech stories that made headlines in 2023
  • Top themes of 2023: AI, precision medicine, virtual care, digital therapeutics
  • ‘The doctor will call you now’ – why telemedicine is here to stay
  • AI is reimagining imaging, but how far can we go today?
  • Removing inequities and biases in wearables
  • Renal denervation for hypertension: game-changing or hype-inducing?
  • AI is a pillar of tomorrow’s healthcare system, but limitations remain
  • No more Dr Google: the rise of symptom checking apps
  • Medtech outlook 2024
  • Top themes for the healthcare sector in 2024
  • Listings
  • Events
  • Buyer's Guides
  • Repsol
  • TS Quality & Engineering
  • Next issue
12/07/2023 00:00:00